Last month, an accountability court in Karachi told NAB to file a reference against Dr Asim by March 5, expressing displeasure at delay in the court proceedings.
On August 26 last year, paramilitary Rangers took Dr Asim, the close confidante of former president Asif Ali Zardari, into custody for his alleged involvement in embezzling millions of rupees, including medical treatment to terrorists.
Accountability courts upset with delays in Dr Asim Hussain reference
While talking to The Express Tribune, the source added that the case will be filed against Dr Asim to put him on trial for alleged large-scale corruption.
Dr Asim’s collaborators, senior officials from Oil and Gas Development Company Limited (OGDCL) and Sui Southern Gas Company Limited (SSGCL), will also face the trial as the co-accused, he said.
Further, the source said NAB investigators had also conducted investigation against the officials producing documents of the scam.
NAB to file reference against Dr Asim
Besides the main accused, three former managing directors and a serving MD of SSGCL and some other officials were found involved in the illegal deal, the source maintained.
On February 22, an investigator officer told the court that investigation into five charges, including corruption, misappropriation, creating artificial shortage of natural gas, money laundering, illegal use of his private hospital and land grabbing, had been finalised.
The former federal minister was accused of financial irregularities and favoritism while awarding contracts to a private company, causing a loss of Rs17.338 billion to the exchequer.
Facing terrorism, corruption charges: Dr Asim breaks silence, shares untold stories
Besides misappropriation of money, Dr Asim was accused of providing treatment to terrorists — militants working for political and religious groups — who were injured in shootouts with the law enforcers or with rival groups.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ